Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab

被引：0
|
作者：
Bachir, B. [1 ]
Anouti, S. [1 ]
Jaoude, J. Abi [1 ]
Kayali, M. [1 ]
Tfayli, A. [1 ]
De Azambuja, E. [2 ]
Poortmans, P. [3 ]
Zeidan, Y. [1 ,4 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[2] ULB, Brussels, Belgium
[3] Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
[4] Baptist Hlth South Florida, Lynn Canc Inst, Boca Raton, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Evaluation of Cardiotoxicity in HER-2-Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab
    Bachir, Bachir
    Anouti, Sirine
    Jaoude, Joseph Abi
    Kayali, Majd
    Tfayli, Arafat
    de Azambuja, Evandro
    Poortmans, Philip
    Zeidan, Youssef H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (01): : 135 - 142
  • [2] Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
    Lopez, M.
    Minguito Carazo, C.
    Delgado Sillero, I.
    Rojas Piedra, M.
    Tavara Silva, B.
    Lopez-Gonzalez, A.
    Castanon Lopez, C.
    Nieto Mangudo, B.
    Pedraza Lorenzo, M.
    Rodriguez Sanchez, A.
    Diz Tain, P.
    De Sande Gonzalez, L. M.
    Medina Valdivieso, S.
    Lopez Gonzalez, L.
    Honrado Franco, E.
    Garcia-Palomo, A.
    Sanchez-Cousido, L. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S332 - S332
  • [3] Cardiotoxicity in HER-2 positive patients, with advanced breast cancer, receiving several years of treatment with trastuzumab
    Larsen, A. K.
    Jensen, A. B.
    Langkjer, S. T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S183 - S184
  • [4] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [5] Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy
    Nunes, Raquel A.
    Li, Xiaochun
    Kang, Soonmo Peter
    Burstein, Harold
    Roberts, Lisa
    Carney, Walter
    Blackwell, Kimberly
    Ryan, Paula
    Borges, Virginia
    Iglehart, J. Dirk
    Friedman, Paula
    Harris, Lyndsay N.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (01): : 1 - 10
  • [6] Risk factors and clinical relevance of cardiotoxicity in her2 positive breast cancer patients treated with trastuzumab
    Minguito Carazo, C. Carlos
    Lopez Flores, M.
    Sanchez Cousido, L. F.
    Lopez Gonzalez, A.
    Rodriguez Santamarta, M.
    Tundidor Sanz, E.
    Echarte Morales, J.
    Sanchez Munoz, E.
    Garcia Palomo, A.
    Fernandez Vazquez, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 37 - 37
  • [7] Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab
    Jiang, Shuai
    Geng, Shuai
    Gao, Xinyue
    Liu, Tong
    Luo, Xinyu
    Wang, Nan
    Shi, Ning
    Dong, Mei
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2023, 45 (05) : 616 - 625
  • [8] Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy
    Otchere, Prince
    Adekoya, Olusola
    Governor, Samuel B. B.
    Vuppuluri, Naveen
    Prabhakar, Akruti
    Pak, Stella
    Oppong-Nkrumah, Oduro
    Cook, Francis
    Bohinc, Rudy
    Aune, Gregory
    CARDIO-ONCOLOGY, 2023, 9 (01)
  • [9] Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
    Sagar Sardesai
    Jasmine Sukumar
    Mahmoud Kassem
    Marilly Palettas
    Julie Stephens
    Evan Morgan
    Daniel Addison
    Ragavendra Baliga
    Daniel G. Stover
    Jeffrey VanDeusen
    Nicole Williams
    Mathew Cherian
    Maryam Lustberg
    Robert Wesolowski
    Bhuvaneswari Ramaswamy
    Cardio-Oncology, 6
  • [10] Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
    Sardesai, Sagar
    Sukumar, Jasmine
    Kassem, Mahmoud
    Palettas, Marilly
    Stephens, Julie
    Morgan, Evan
    Addison, Daniel
    Baliga, Ragavendra
    Stover, Daniel G.
    VanDeusen, Jeffrey
    Williams, Nicole
    Cherian, Mathew
    Lustberg, Maryam
    Wesolowski, Robert
    Ramaswamy, Bhuvaneswari
    CARDIO-ONCOLOGY, 2020, 6 (01)
12345